No results for ‘’
Laurus Labs Ltd
₹1419.80
(0.32%)
Tue, 16 Jun 2026, 09:28 am
Health Technology
Pharmaceuticals: Major
24.5KLaurus Labs Price to Sales Ratio (P/S)
| Particulars | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 24.80 | 31.92 | 45.41 | 13.48 | 19.81 | 38.44 | 20.01 | 131.68 | 92.43 |
| Price to book ratio | 0 | 0 | 0 | 4.10 | 3.60 | 2.73 | 1.95 | 7.48 | 9.46 | 3.91 | 5.14 | 7.40 |
| Price to sales ratio | 0 | 0 | 0 | 2.49 | 2.64 | 1.88 | 1.23 | 4.07 | 6.45 | 2.62 | 4.19 | 5.96 |
| Price to cash flow ratio | 0 | 0 | 0 | 19.67 | 20.03 | 19.89 | 13.11 | 28.81 | 38.43 | 18.43 | 42.54 | 83.10 |
| Enterprise value | 0 | 0 | 0 | 5529Cr | 6327Cr | 5291Cr | 4520Cr | 20919Cr | 33522Cr | 17788Cr | 23582Cr | 35870Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 13.82 | 15.96 | 15.32 | 8.58 | 13.70 | 23.28 | 10.86 | 29.33 | 33.10 |
| Debt to equity ratio | 1.51 | 1.13 | 1.20 | 0.63 | 0.66 | 0.66 | 0.61 | 0.57 | 0.53 | 0.50 | 0.63 | 0.62 |
| Return on equity % | 0 | 12.62 | 16.92 | 17.40 | 11.92 | 6.17 | 15.34 | 45.04 | 27.82 | 21.39 | 3.94 | 8.35 |
Laurus Labs Ltd Price to Sales Ratio
The Laurus Labs Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Laurus Labs Ltd's valuation, profitability, and overall financial performance. Tracking the Laurus Labs Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Laurus Labs Ltd (NSE: LAURUSLABS, BSE: 540222) is currently trading at ₹1419.80, with a market capitalization of ₹75825.56Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Laurus Labs Ltd Price to Sales Ratio is essential for fundamental analysis.
Laurus Labs Ltd Price to Sales Ratio Current Value
The current Laurus Labs Ltd Price to Sales Ratio stands at 5.96.
The latest Laurus Labs Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Laurus Labs Ltd Price to Sales Ratio Historical Trend
The Laurus Labs Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 5.96
- 2023: 4.19
- 2022: 2.62
- 2021: 6.45
- 2020: 4.07
The recent rise in Laurus Labs Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.
What Laurus Labs Ltd Price to Sales Ratio Indicates for Investors
The Laurus Labs Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Laurus Labs Ltd Price to Sales Ratio Analysis Summary
The Laurus Labs Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Laurus Labs Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Laurus Labs Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.